A

AARD

Aardvark Therapeutics

8.74

-1.40-13.81%
After Hours: 9.17  +0.43  +4.92%17:08 05/14 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
Total Revenue

0

0

0

Net Income

-20.59M

-7.21M

-13.56M

ROE

-0.507

-0.5747

--

ROA

-0.4677

-0.5282

--

EPS

-0.9628

-0.3371

-0.6343

BVPS

3.3722

0.4256

0.7473

Asset Turnover

0

0

--

Debt-to-Asset

0.0696

0.1361

0.0463

Current Ratio

15.0471

7.5022

27.716

Quick Ratio

--

--

--